3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
6
Glioma
2
Brain Neoplasms
2
Stroke
1
Neurologic Manifestations
1
Neoplasms
1
Margins of Excision
1
Gliosarcoma
1
Communication
1
Central Nervous System Neoplasms
1
Caregiver Burden
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Interventions
Bevacizumab
4
Temozolomide
3
Irinotecan
3
Sorafenib
2
pembrolizumab
1
ibrutinib
1
Vorinostat
1
Valproic Acid
1
Transcranial Magnetic Stimulation
1
Therapeutics
1
Thalidomide
1
Surveys and Questionnaires
1
Sildenafil Citrate
1
Radiosurgery
1
Pliability
1
Palliative Care
1
Lenalidomide
1
Laparoscopy
1
Exercise
1
Equipment and Supplies
1
Carboplatin
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurologic Manifestations
×
Palliative Care
×
CNS
×
Clear all
NCT07590726
2026-05-19
PIRe
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
160 enrolled